BS

Biswanath Samal

Active Director Director DIN 10508904
DIN 10508904 First appointment Feb 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Biswanath Samal

Data last updated:

Biswanath Samal is a Director at Boonk2k Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10508904
Primary Designation Director
Industry Pharma
First Appointment 15 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Feb 20242024Active

Board colleagues of Biswanath Samal

NameDINCompanyDesignation
Srikanth Jummerath10508905Boonk2k Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Boonk2k Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Biswanath Samal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biswanath Samal

Biswanath Samal currently holds 1 directorship: Boonk2k Pharmaceuticals Private Limited (Director, since 15 Feb 2024).

Biswanath Samal was first appointed on 15 Feb 2024 as Director at Boonk2k Pharmaceuticals Private Limited.

The current boards of Biswanath Samal's companies include Srikanth Jummerath (Boonk2k Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available